Matches in SemOpenAlex for { <https://semopenalex.org/work/W85207877> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W85207877 endingPage "802" @default.
- W85207877 startingPage "795" @default.
- W85207877 abstract "Aortic stenosis (AS) is the most frequent heart valve disease in western countries, and its prevalence increases with age. Sutureless valves have recently become available that allow the surgical procedures to be shortened. The study aim was to assess clinical outcome after sutureless aortic valve replacement (SAVR) performed with the Perceval S bioprosthesis at the authors' institution.Between June 2007 and November 2011, a total of 143 patients (78 females, 65 males; mean age 79.4 +/- 5.9 years) was prospectively enrolled and followed at the authors' center. The median preoperative logistic EuroSCORE was 12.04 +/- 10.7. Preoperatively, 58.8% of patients were in NYHA class III or IV, and the mean gradient and effective orifice area (EOA) were 38.8 +/- 17 mmHg and 0.76 +/- 0.24 cm2, respectively. Isolated SAVR was performed in 95 patients (66.4%), while associated procedures were necessary in 48 patients (33.6%). The follow up was 100% complete (mean 13.4 +/- 11.6 months; range: 0-5 years; total cumulative follow up 155 patient-years).The procedural success rate was 99.3%. The mean cross-clamp and cardiopulmonary bypass times were 32.0 +/- 14.9 min and 44.7 +/- 18.6 min, respectively. In-hospital mortality was 4.9% (n=7). Pacemaker implantation was required in seven patients (4.9%). Survival at five years was 85.5%. Reoperation was necessary in seven patients (4.9%); early reoperations were due to paravalvular leak (n = 3; 2.0%) and intra-prosthetic regurgitation (n=3; 2.0%). One late reoperation (at 29 months) was required, due to fibrous pannus overgrowth. One late endocarditis (0.7%) occurred at 26 months and was medically treated. No structural valve deterioration occurred during the follow up. At 12 months, 94.4% of survivors were in NYHA class I-II, and the mean pressure gradient and EOA were 9.0 +/- 3.4 mmHg and 1.60 +/- 0.3 cm2, respectively.The Perceval S valve appears to be a safe option for SAVR, though further follow up is needed to evaluate the long-term outcome with this bioprosthesis." @default.
- W85207877 created "2016-06-24" @default.
- W85207877 creator A5000332038 @default.
- W85207877 creator A5007620592 @default.
- W85207877 creator A5016161614 @default.
- W85207877 creator A5030055202 @default.
- W85207877 creator A5035501380 @default.
- W85207877 creator A5048949867 @default.
- W85207877 creator A5061853114 @default.
- W85207877 creator A5082202905 @default.
- W85207877 creator A5086672951 @default.
- W85207877 date "2014-11-01" @default.
- W85207877 modified "2023-09-23" @default.
- W85207877 title "Aortic valve replacement with the perceval S bioprosthesis: single-center experience in 143 patients." @default.
- W85207877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25790630" @default.
- W85207877 hasPublicationYear "2014" @default.
- W85207877 type Work @default.
- W85207877 sameAs 85207877 @default.
- W85207877 citedByCount "11" @default.
- W85207877 countsByYear W852078772016 @default.
- W85207877 countsByYear W852078772017 @default.
- W85207877 countsByYear W852078772018 @default.
- W85207877 countsByYear W852078772019 @default.
- W85207877 countsByYear W852078772020 @default.
- W85207877 countsByYear W852078772022 @default.
- W85207877 countsByYear W852078772023 @default.
- W85207877 crossrefType "journal-article" @default.
- W85207877 hasAuthorship W85207877A5000332038 @default.
- W85207877 hasAuthorship W85207877A5007620592 @default.
- W85207877 hasAuthorship W85207877A5016161614 @default.
- W85207877 hasAuthorship W85207877A5030055202 @default.
- W85207877 hasAuthorship W85207877A5035501380 @default.
- W85207877 hasAuthorship W85207877A5048949867 @default.
- W85207877 hasAuthorship W85207877A5061853114 @default.
- W85207877 hasAuthorship W85207877A5082202905 @default.
- W85207877 hasAuthorship W85207877A5086672951 @default.
- W85207877 hasConcept C126322002 @default.
- W85207877 hasConcept C141071460 @default.
- W85207877 hasConcept C164705383 @default.
- W85207877 hasConcept C2776570981 @default.
- W85207877 hasConcept C2780007028 @default.
- W85207877 hasConcept C2780073493 @default.
- W85207877 hasConcept C2780168065 @default.
- W85207877 hasConcept C2780714102 @default.
- W85207877 hasConcept C2781414266 @default.
- W85207877 hasConcept C71924100 @default.
- W85207877 hasConceptScore W85207877C126322002 @default.
- W85207877 hasConceptScore W85207877C141071460 @default.
- W85207877 hasConceptScore W85207877C164705383 @default.
- W85207877 hasConceptScore W85207877C2776570981 @default.
- W85207877 hasConceptScore W85207877C2780007028 @default.
- W85207877 hasConceptScore W85207877C2780073493 @default.
- W85207877 hasConceptScore W85207877C2780168065 @default.
- W85207877 hasConceptScore W85207877C2780714102 @default.
- W85207877 hasConceptScore W85207877C2781414266 @default.
- W85207877 hasConceptScore W85207877C71924100 @default.
- W85207877 hasIssue "6" @default.
- W85207877 hasLocation W852078771 @default.
- W85207877 hasOpenAccess W85207877 @default.
- W85207877 hasPrimaryLocation W852078771 @default.
- W85207877 hasRelatedWork W1987535532 @default.
- W85207877 hasRelatedWork W2006155408 @default.
- W85207877 hasRelatedWork W2015268817 @default.
- W85207877 hasRelatedWork W2411399317 @default.
- W85207877 hasRelatedWork W2413550614 @default.
- W85207877 hasRelatedWork W2435225886 @default.
- W85207877 hasRelatedWork W2462155031 @default.
- W85207877 hasRelatedWork W2979761072 @default.
- W85207877 hasRelatedWork W4226229598 @default.
- W85207877 hasRelatedWork W4236733721 @default.
- W85207877 hasVolume "23" @default.
- W85207877 isParatext "false" @default.
- W85207877 isRetracted "false" @default.
- W85207877 magId "85207877" @default.
- W85207877 workType "article" @default.